Detalles de la búsqueda
1.
A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings.
J Acquir Immune Defic Syndr;
87(1): 680-687, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587510
Resultados
1 -
1
de 1
1
Próxima >
>>